Posts in category Business Standard
Lupin gets USFDA approval for Bromfenac Ophthalmic Solution (07-02-2024)
Lupin said that it has received US Food and Drug Administration (USFDA) approval for its abbreviated new drug application for Bromfenac Ophthalmic Solution to market a drug.
US Market closes higher; Dow leads gains (07-02-2024)
Market upside was, however, capped as some traders seemed reluctant to make significant moves amid uncertainty about the near-term outlook for the markets after remarks from Federal Reserve Chair Jerome Powell indicated that cuts may come much later than previously expected. Meanwhile, lack of major U.S. economic data also kept some traders on the sidelines.
Stocks to Watch today, Feb 7: Nykaa, ONGC, UPL, Britannia, Biocon, Paytm (07-02-2024)
Stocks to Watch on Wednesday, February 7, 2024: The parent company of Nykaa nearly doubled its consolidated net profit to Rs 16.2 crore during Q3FY24
Highways Infrastructure Trust consolidated net profit declines 41.37% in the December 2023 quarter (07-02-2024)
Sales rise 39.92% to Rs 231.30 crore
Indag Rubber standalone net profit rises 6.43% in the December 2023 quarter (07-02-2024)
Sales rise 3.11% to Rs 62.33 crore
Patback Business reports standalone net loss of Rs 0.04 crore in the December 2023 quarter (07-02-2024)
Sales reported at Rs 0.91 crore
Shardul Securities consolidated net profit rises 995.45% in the December 2023 quarter (07-02-2024)
Sales rise 1018.94% to Rs 59.08 crore
Raghuvir Synthetics reports consolidated net profit of Rs 1.29 crore in the December 2023 quarter (07-02-2024)
Sales rise 134.98% to Rs 61.87 crore
Mangalam Seeds consolidated net profit rises 63.44% in the December 2023 quarter (07-02-2024)
Sales rise 148.41% to Rs 52.29 crore